Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-09

Clinical Trial Update: Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating hepatic function after five days of acetaminophen dosing in individuals with alcohol-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Alcohol Related Disorders | Phase 4 | Status: COMPLETED